OC
STJ

Oppenheimer & Co’s St Jude Medical STJ Stock Holding History

Oppenheimer & Co’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-34,490
Closed -$2.18M – 1423
2015
Q3 		$2.18M Sell
34,490
-1,529
-4% -$109K 0.07% 341
2015
Q2 		$2.63M Sell
36,019
-585
-2% -$42.3K 0.07% 310
2015
Q1 		$2.39M Buy
36,604
+26,325
+256% +$1.75M 0.07% 347
2014
Q4 		$669K Buy
10,279
+4,347
+73% +$280K 0.02% 727
2014
Q3 		$357K Buy
+5,932
New +$388K 0.01% 996

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Oppenheimer & Co's STJ Position: Q4 2015 in Review

Oppenheimer & Co sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 34,490 shares — an estimated $2.18M sold.

Oppenheimer & Co first reported a position in STJ in Q3 2014 and held it in 5 quarters. The position peaked at $2.63M in Q2 2015. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Oppenheimer & Co reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 34,490 St Jude Medical shares in Q4 2015, an estimated $2.18M.
  • Oppenheimer & Co first reported a position in St Jude Medical in Q3 2014 and held it in 5 quarters.
  • Oppenheimer & Co's St Jude Medical position peaked at $2.63M in Q2 2015.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.